QC & QA compliance requirement for final release Flashcards

1
Q

Describe the Quality Management diagram

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

QA systems ensures that:

A
  • Products are designed & developed to GMP
  • Controls on the environment
  • Controls on starting, intermediate & finished products
  • Operators competent to perform functions
  • Correct system for “release”
  • Storage & distribution consistent with shelf life
  • Pharmaceutical Quality System operates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the definition of ‘Quality Control’?

A

…concerned with:

  • Sampling, specifications, and testing
  • Organisation, documentation and release procedures

Which ensure that the necessary and relevant tests are actually carried out and that materials are not released for use until their quality has been judged to be satisfactory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the main requirements of QC?

A
  • Adequate facilities, trained personnel & approved procedures are available
  • Samples are taken from all parts of the process and retained samples kept for future testing
  • Test methods are validated
  • Records made of sampling + deviations
  • Qualitative and Quantitative tests comply
  • Tests encompass product in container with label
  • Participate in investigations of complaints
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

an Aseptically Prepared Product is…

A
  • Sterile
  • Particle Free
  • Contamination Free
  • Right Patient
  • Right Drug
  • Right Dose, Concentration & Frequency
  • Right Label and Instructions
  • Right Administration Device
  • Appropriate Shelf Life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the requirements of each grade of cleanroom according to the Micro Testing Guidelines (Orange Guide 2015)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe ‘Air Monitoring’

A
  • Air acts as a carrier of contamination
  • Quantitative analysis
  • Known volume of air
  • Impaction/centrifugal forces used
  • Physical stress to bacteria
  • Do not interchange instrument design
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe ‘Fallout methods - settle plate’

A
  • Passive technique
  • Settle out by gravity
  • Simple to measure
  • No physical stress to bacteria
  • Represents <0.2% of working surface
  • Consistent position required
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe ‘Surface monitoring - contact plate’

A
  • Contact Plates
  • Plate overfilled with media
  • Good surface contact
  • Standardise technique
  • Media should include neutraliser
  • Wash surface after plating to remove agar residues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe ‘Finger Dabs - glover print’

A
  • Monitor personnel
  • Contamination through
    -> Inadvertent contact with contaminated surface
    -> Damaged glove
    -> Excessive personnel shedding
    Standardise technique
    Clean gloves/change afterwards
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sterility testing takes around 14 days, why is this an issue?

A

Shelf-life 3 hours to 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sterility testing only tests container sampled, why is this an issue?

A

Batch size from 1 to 100s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sterility testing is a poor indicator if low levels of contamination, why is this a problem?

A

Grade A

Staff validated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In-process testing usually consists of…

A

Quick testing methods performed prior to filling e.g.

Flame photometry
- Metal ion content

UV absorption

  • Identification of drug
  • Content
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

End-process testing usually consists of…

A

HPLC

Atomic absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the main risks associated with having air in the syringe?

A

Risk of air embolism in patient
- fatality dependant on volume and rate

Incorrect volume and solution (patient recieving low dose)

Implications for stability & infusion rate

17
Q

What are the main risks associated with an incomplete bung seal?

A

Reduction in safety barriers to user

Risk of integrity of syringe being compromised

18
Q

What are the main risks associated with drug in the bung?

A

Risk of contamination to user

Integrity of syringe has been compromised exposing the contents of the syringe to microbiological contamination

19
Q

What are the main risks associated with drug in the hub?

A

Risk of exposure to cytotoxic drugs

Creates a fluid pathway for microbiological contamination into the solution

20
Q

What can be done to try and ensure that the final product is contamination free?

A

Licensed starting material

CE marked devices & components

Appropriate segreation

Appropriate diluent

Appropritate shelf-life & stability studies

Validated cleaning procedures

Demonstrate cross-contamination not occurring

21
Q

What should normally be checked during the final release process?

A

Good written communication

Documentation record complies with data integrity requirements

Checks on patient ID

Correct transcription of product requirements

Right administration device

Formula

Ingredient checks

Method

Equipment

Label

Process

22
Q

What is the pharmacists responsibility in the final release process?

A

Release assured by familiarisation with QA processes:

  • Starting material approval
  • Accurate documentation
  • Knowledge
  • Supervision
  • Trained staff
  • Validation
  • Monitoring
  • Deviations
  • Audit